BRTX vs IT · rev $401.0K vs P/E 16, rev $6.27B
BioRestorative Therapies Inc (BRTX) versus Gartner Inc (IT) — a side-by-side from cached financials, not a winner call.
BioRestorative Therapies Inc (BRTX) is a biotechnology company listed on NASDAQ.
Gartner Inc (IT) is a information technology services company listed on US.
Latest reported BRTX revenue for 2024-12-31 was $401.0K. Net income was -$9.0M. Revenue was up 175.0% from 2023-12-31 to 2024-12-31. BRTX currently screens at market cap $10.2M.
Latest reported IT revenue for 2024-12-31 was $6.27B. Net income was $1.25B. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. IT currently screens at market cap $11.03B and trailing P/E 16.3.
BRTX currently screens at market cap $10.2M. IT currently screens at market cap $11.03B and trailing P/E 16.3.
Not investment advice. Open the BRTX and IT stock pages for the full models.
Not investment advice.